Abstract
Reducing agents cysteine, glutathione and dithiothreitol in the concentration range of 10 µM-10 mM diminished binding of [3H]3-quinuclidinyl benzilate ([3H]3-QNB) to in situ muscarinic receptor sites of membranes from rat cerebral cortex. The thiol reagents N-ethylmaleimide, pCMB, and Cd2+ and the oxidizing agent 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) in low concentrations (10 µM-10 mM) have also diminished muscarinic binding causing an approximately 50% inhibition at 50 µM concentration. Treatment of membranes with reducing- or thiol-reagents diminished the number of antagonist and agonist binding sites and changed the affinity toward these ligands. The apparent Kd value for [3H]3-QNB binding increased from 0.4 nM to 0.7-0.8 nM as a result of covalent modification of the membranes. The binding of carbamylcholine as determined from competition with [3H]3-QNB (0.1 mM) could be described with a two-site model with apparent Kd values 95 ± 15 µM and 52 ± 8 nM, respectively. In treated membranes these values were altered to 36-230 µM and 0.5-5 µM, respectively. The results suggested that a disulfide bond, which could be reduced and reoxidized, may play an important role in ligand binding. Furthermore, experiments with N-ethylmaleimide, pCMB, and DTNB suggested the presence of thiol groups of importance for the binding. The finding that Cd2+ inhibited ligand binding in low concentrations (50 µM) suggested the presence of vicinal thiol groups. Modification of thiol-disulfide state of receptor may be involved in the control of binding activity.
ACKNOWLEDGMENT The authors want to thank Dr. Bengt Mannervik for valuable discussions.
- Copyright © 1979 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|